Tendinopathy

2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

BT
2 programs
2
SM04755Phase 11 trial
SM04755Phase 11 trial
Active Trials
NCT03502434CompletedEst. Nov 2017
NCT03229291CompletedEst. Jun 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Biosplice TherapeuticsSM04755
Biosplice TherapeuticsSM04755

Clinical Trials (2)

NCT03502434Biosplice TherapeuticsSM04755

A Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution in Healthy Volunteers

Start: Sep 2017Est. completion: Nov 2017
Phase 1Completed
NCT03229291Biosplice TherapeuticsSM04755

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SM04755 Following Topical Administration to Healthy Subjects

Start: Nov 2016Est. completion: Jun 2017
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space